In a regulatory filing, Treace Medical (TMCI) disclosed that its CEO John Treace bought 60K shares of common stock on March 4th in a total transaction size of $524K. Shares of Treace Medical are up 4% afterhours at $9.20.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMCI: